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Abstract: Chitosan/alginate nanoparticles which had been optimized in our previous study 
using two different N/P ratios were chosen and their ability to release epidermal growth factor 
receptor (EGFR) antisense was investigated. In addition, the stability of these nanoparticles in 
aqueous medium and after freeze-drying was investigated. In the case of both N/P ratios (5, 25), 
nanoparticles started releasing EGFR antisense as soon as they were exposed to the medium 
and the release lasted for approximately 50 hours. Nanoparticle size, shape, zeta potential, and 
release profile did not show any significant change after the freeze-drying process (followed by 
reswelling). The nanoparticles were reswellable again after freeze-drying in phosphate buffer 
with a pH of 7.4 over a period of six hours. Agarose gel electrophoresis of the nanoparticles 
with the two different N/P ratios showed that these nanoparticles could protect EGFR antisense 
molecules for six hours.
Keywords: chitosan/alginate nanoparticles, release profile, freeze-drying, agarose gel 
electrophoresis
Introduction
Nanoparticles made from polyelectrolyte complexation have shown potential for use 
as drug delivery systems. Polyelectrolyte complexes are formed when oppositely 
charged polyelectrolytes are mixed and interact electrostatically. Chitosan and alginate 
are polycation and polyanion polyelectrolytes, respectively, that can be used to form 
a polyelectrolyte complex and to deliver proteins, peptidic drugs, and DNA.1
The incorporation of secondary polymers has been one approach used to improve 
the characteristics of liposome and/or polycation nonviral systems.2
Chitosan is a natural linear polysaccharide composed of D-glucosamine and 
N-acetyl-D-glucosamine units, and is cationic at acidic and neutral pH. Its cationic nature 
allows it to interact with and easily form complexes with negatively charged DNA.
Chitosan-DNA nanoparticles generally transfect cells more efficiently than naked 
DNA, but to a lesser extent than commercially available liposome formulations. It has 
been suggested that the strength of the interaction between chitosan and DNA results in 
highly stable particles, thereby preventing dissociation within the cell, and ultimately 
precluding translation of the DNA, resulting in low transfection. Support for this 
hypothesis comes from studies of the intracellular fate of chitosan-DNA nanopar-
ticles demonstrating that these particles remain intact intracellularly for several days. 
Formulations facilitating the release of DNA, such as those including hydrophobic 
moieties or with the addition of an anionic polymer, could improve chitosan-based 
vector transfection.3International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
456
Azizi et al
Alginate is an anionic copolymer of 1, 4-linked β-D 
  mannuronic acid and α-L-guluronic acid residues. In the 
presence of divalent cations such as calcium, alginate forms 
a gel, due to the stacking of guluronic acid blocks with the 
formation of “egg-box” calcium-linked junctions.4
In the present study, due to a number of desirable charac-
teristics and the demonstrated success of the alginate-chitosan 
(Alg/Chi) system, it was decided to explore its development 
and use in the submicron scale and to evaluate its potential 
use as a stable carrier during preparation and storage.
For this purpose, Alg/Chi nanoparticles were produced 
based on the formation of a polyionic complex between two 
biopolymers. Pregel preparation was carried out using alg-
inate and calcium chloride. Chitosan and epidermal growth 
factor receptor (EGFR) antisense oligonucleotide (EGFR 
AS) solutions were subsequently added to the pregel for 
preparing nanoparticles of EGFR AS.
EGFR AS was used to reduce the expression of EGFR, 
a receptor tyrosine kinase proto-oncogene that plays a 
central role in the initiation and development of several 
human malignancies, notably of the breast, brain, and lung.5 
Based on the results of size and zeta potential optimization 
of nanoparticles in our previous study,6 two different N/P 
ratios were chosen as the best formulations, and the release 
profiles of EGFR AS from these two nanoparticles were 
evaluated.
The macromolecular drug can degrade during preparation 
of the nanoparticles, during storage, and also during in vitro 
or in vivo release. For example, the drug may be exposed to 
heat, shearing forces, pH extremes, organic solvents, inter-
faces, freezing, and drying during preparation of the nano-
particles.7 Therefore, evaluation of nanoparticle stability is 
necessary to confirm the suitability of Alg/Chi nanoparticles 
for antisense delivery.
Nanoparticle stability is necessary for protection of extra-
cellular oligonucleotide molecules. Agarose gel electropho-
resis has been used to observe the electrophoretic migration 
behavior and has confirmed that nanoparticles can protect 
antisense oligonucleotide molecules from dissociation during 
their preparation and also their exposure to cells.8
The stability of antisense-loaded nanoparticles was 
investigated in aqueous medium (using agarose gel 
  electrophoresis) and after freeze-drying to evaluate the 
efficacy of nanoparticles as an antisense vehicle. Size, zeta 
potential, scanning electron microscopy (SEM) images, and 
release profiles of nanoparticles were compared before and 
after freeze-drying to determine if there were any changes 
in these characteristics after freeze-drying.
Chitosan and alginate have high pH-dependent swelling 
properties, which could be used to control the release of 
drugs.9,10 It is well established that water exists in polymer 
networks of hydrogels in three different physical states, 
ie, free water that can freeze at the usual freezing point, 
intermediate water that freezes at a temperature lower than 
the usual freezing point, and bond water which cannot freeze 
at the usual freezing point. Biomedical or pharmaceutical 
activity depends on how the water molecules associate 
with the polymer. Moreover, the swelling characteristics of 
hydrogels are dominated by the nature of the polymer and the 
state of water.9 The ability of the nanoparticles to swell was 
investigated by evaluation of their size increase in medium 
buffer after freeze-drying, to ensure that the nanoparticles 
could be reswelled again in aqueous solution and release 
their drug content during swelling.
The unchanged characteristics of antisense-loaded Alg/
Chi nanoparticles after freeze-drying and also the ability 
of these nanoparticles to protect the antisense molecules 
from degradation in aqueous medium were important rea-
sons to investigate the usefulness of this antisense delivery 
system.
Materials and methods
Materials
Guluronate-rich sodium alginate (BDH Co., UK) in which the 
M/G ratio and viscosity of a 1.0% W/V solution is 0.31 and 
38 cp, respectively, low molecular weight chitosan (Sigma-
Aldrich Co., Germany), and calcium chloride (Merck KGaA 
Co., Germany), EGFR phosphorothioated 21 mer antisense 
5' (TTTCTTTTCCTCCAGAGCCCG) 3' (TIB MOLBIOL® 
GmbH., Germany) were used.
An optimized formulation of particles was prepared as 
previously described by Gazori et al by adding chitosan-
antisense solution to calcium alginate pregel at pre-defined 
concentrations.6
Particle size and zeta potential
Nanoparticle size and zeta potential were assessed by photon 
correlation spectroscopy using a Malvern zetasizer/scattering 
particle size analyzer (Malvern ZS Series Co., UK). To do 
this, a sample of 2 mL was vortexed, placed into an analyzer 
chamber, and measured.
Nanoparticle morphology, such as shape and presence of 
aggregates, was studied by SEM. Samples of nanoparticles 
were mounted on metal stubs, coated with platinum under 
vacuum, and then examined on a LEO1455 VP electron 
microscope (10 kV , Cambridge).International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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Drug release
The drug release study was performed using the dialysis 
sack method with 23 × 15 mm DO-405 dialysis tubing 
(Sigma, Germany). Antisense-loaded nanoparticles contain-
ing 63 µg of antisense were added to the dialysis bag with a 
molecular cutoff of 10–12 kDa. The bag was then sealed and 
placed in a beaker containing 100 mL of phosphate buffer 
(pH 7.4) with an agitation rate of 300 rpm on a magnetic 
stirrer. Samples were taken at intervals for four days and 
replaced with fresh phosphate buffer. The samples were 
analyzed spectrophotometrically at 260 nm, and the release 
percentage in each interval was calculated. The stability of 
the nanoparticles after freeze-drying and also in aqueous 
medium was examined.
Nanoparticle freeze-drying
Nanoparticle suspensions were frozen at −20°C for 24 hours 
and then lyophilized in (Christ, Alpha 2–4 Lyophilizator, 
Germany). The lyophilized particles were resuspended and 
evaluated for size, zeta potential, shape, and release profile 
to determine if nanoparticle characteristics were affected by 
the lyophilization process.
gel electrophoresis
A 2% agarose solution in Tris, acetic acid, and ethylenedi-
aminetetraacetate buffer was prepared, and 0.1% ethidium 
bromide was added to the solution to prepare the agarose 
gel. Nanoparticles with two different N/P ratios (5, 25) 
were produced in three different series. In the first series, 
nanoparticles were incubated in aqueous medium for 
six hours; in the second series, nanoparticles were prepared 
by incubation for three hours; and the third series comprised 
freshly prepared nanoparticles. The three series of loaded 
nanoparticles, as well as naked EGFR AS and nanoparticles 
without EGFR AS, were mixed with loading dye and put into 
agarose gel wells separately; 6 µg of antisense was used in 
all cases. Samples in agarose gel were then electrophoresed 
for 60 minutes at 75 V . The resulting gel was viewed under 
ultraviolet (UV) illumination and photographs were taken 
using a UV documentation device (Bio Doc-IT System, 
Upland, CA).
Particle preparation yields were calculated by dividing 
the weight ratios of the nanoparticles on applied polymers 
and multiplying by 100.
After the freeze-drying process, the nanoparticles were 
placed in phosphate buffered saline (pH 7.4) while stirring, 
and at a series of intervals their size was assessed by a 
Malvern zeta sizer over eight hours.
statistical analysis
For all the results, triplicate readings were obtained for a 
minimum of three separate samples. For comparison of 
means before and after the freeze-drying process, paired 
t-tests were applied to the means ± standard deviation (SD). 
A P value , 0.05 was considered to be significantly differ-
ent in all cases.
Results and discussion
Nanoparticle size
The optimized formulation which had the smallest size 
(194 nm), good monodispersity, and good loading efficacy 
(95.6%) was chosen on the basis of the results of our previous 
study. The composition of this formulation was a Chi/Alg 
ratio of 1, calcium chloride 0.2%, and N/P ratio of 5. A second 
formulation had a Chi/Alg ratio of 1, calcium chloride 0.2%, 
an N/P ratio of 25, with a particle size of 430 nm and loading 
efficacy of 66.5%. Antisense was added to the chitosan solution 
and this complex was added to the calcium alginate pregel. Oli-
gonucleotide molecules with negative electrostatic force bind to 
chitosan which has a positive electrostatic force, causing load-
ing of antisense molecules to the Alg/Chi nanoparticles.11
The second formulation with an N/P ratio of 25 was 
also compared with the formulation having an N/P ratio of 
5, because in future studies we intend to check the prepared 
  nanoparticles in cell culture with at least two different 
N/P ratios. Therefore, the release capability and stability 
of these formulations were checked as part of this study 
(see Table 1).
Table 1 Nanoparticle size and zeta potential before and after the freeze-drying process
Nanoparticles  
size (nm)
Zeta potential 
(mV)
Burst release % 
(up to 15 min)
T 100% 
(h)
Alg/chi-As BFDa 196 ± 12 30.0 ± 4.1 58.3 ± 2.3 50.0 ± 0.5
N/P 5 AFDb 185 ± 8 25.0 ± 5.3 56.5 ± 2.7 51.0 ± 1.0
Alg/chi-As BFD 430 ± 21 43.0 ± 3.3 50.6 ± 1.6 45.0 ± 0.7
N/P 25 AFD 425 ± 26 46.0 ± 2.7 51.3 ± 2.1 43.0 ± 1.2
Notes: aBefore freeze-drying. bAfter freeze-drying.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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The preparation yields of nanoparticles having N/P 
ratios of 5 and 25 were 73.4% ± 4.2% and 62.8% ± 5.4%, 
respectively. This could be referred to a larger N/P ratio of 
25 which may cause faster aggregation than an N/P ratio of 
5, resulting in fewer yields.
SEM images showed that nanoparticles have a spherical 
shape and are monodispersed. The SEM images of freeze-dried 
nanoparticles which were resuspended and then prepared for 
SEM imaging also showed particles of the same shape and 
size with very few aggregates. It seems that the freeze-drying 
process does not affect the physical characteristics of these 
nanoparticles. Therefore, this is a good way to store the nano-
particles and increase their shelf-life when they are to be used 
as a drug-delivery system (Figures 1A and 1B, and Table 1).
Nanoparticle zeta potentials
Zeta potentials for the two formulations with N/P ratios of 
5 and 25 were 30 ± 4.1 mV and 43 ± 3.3 mV ,   respectively. 
It was also shown that there was not any significant 
  difference between the zeta potentials of the two formulations 
before and after freeze-drying (see Table 1), which indicates 
the suitability of the freeze-drying process for storage of 
these nanoparticles.
Ability of nanoparticles to swell
Freeze-dried nanoparticles with an N/P ratio of 5 were placed 
in phosphate buffer with a pH of 7.4, and size analysis showed 
that the nanoparticles can be reswelled in medium after 
  freeze-drying within approximately six hours and that there-
after the nanoparticles start to degrade, causing a decrease in 
nanoparticle size (Figure 4). Reswelling is necessary to release 
the antisense molecules from the hydrogel matrices.9
Drug release
Release profiles of nanoparticles made with two different 
N/P ratios of 25 and 5 showed that nanoparticles can release 
antisense over 45 and 50 hours respectively, and that there is 
no significant difference between the release profiles of both 
nanoparticles before and after freeze-drying. Drug diffusion 
out of a hydrogel matrix is dependent on the mesh sizes 
within the matrix of the gel. Typical mesh sizes reported for 
biomedical hydrogels range from 5 to 100 nm (in their swol-
len state), which are much larger than most small-molecule 
drugs. As a result, diffusion of these drugs is not consider-
ably retarded in the swollen state, whereas macromolecules 
like oligonucleotides, due to their hydrodynamic radii, will 
have a sustained release unless the structure and mesh size 
of the swollen hydrogel are designed appropriately to obtain 
desired rates of macromolecular diffusion. In the case of the 
swelling-controlled mechanism, when diffusion of a drug 
is significantly faster than hydrogel distension,   swelling is 
considered to be controlling the release   behavior. Finally, 
chemically controlled release is determined by chemical 
reactions occurring within the gel matrix. These reactions 
500 nm 500 nm
A B
Figure 1 scanning electron microscopy image of alginate-chitosan nanoparticles with an N/P ratio of 5 before (A) and after (B) the freeze-drying process, magnification 50×.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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include polymeric chain cleavage via hydrolytic or enzymatic 
degradation, or reversible/irreversible reactions occurring 
between the previously described release mechanisms. Under 
certain circumstances, surface or bulk erosion of hydrogels 
or the binding equilibrium among the drug-binding moi-
eties incorporated within the hydrogels are two different 
mechanisms reported as controlling the rate of drug release 
(Figure 2).12
Douglas et al reported that Chi/Alg nanoparticles loaded 
by DNA with two different N/P ratios (10, 25) released 6% 
and 3.5% of adsorbed DNA, respectively, in PBS (phosphate-
buffered saline) over 48 hours.2
Borges et al reported that alginate can increase the 
stability of chitosan nanoparticles and reduce the release 
rate of ovalbumin from Alg/Chi nanoparticles .13 In another 
study,14 colloidal complexes of antisense oligonucleotide 
with poly-L-lysine (PLL) and protamine salts were 
formed. Release profiles of antisense oligonucleotide 
were studied in water and PBS at pH 7.4. It was reported 
that the dissociation behavior of antisense with PLL or 
protamine was better enhanced in PBS than in deionized 
water. The phosphate anions probably compete with the 
oligonucleotide to occupy the positive polycation groups 
and this causes dissociation of antisense molecules from 
polycations.14
The release profiles of the formulations investigated in the 
present study were not affected by freeze-drying (Figures 2A 
and 2B), which is essential for a good drug delivery system, 
Figure 2 Release profile of nanoparticles with N/P ratio of 5 and 25 (A) over 50 hours and (B) in the first six hours.
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thereby protecting the drug until it is released at its target 
region (see Table 1).
There is a significant difference between the percent-
age of burst release from nanoparticles with N/P ratios of 
5 and 25 for up to 15 minutes in PBS (Table 1, P # 0.001), 
ie, the burst release from nanoparticles with an N/P ratio of 
25 is significantly lower than that from those with an N/P 
ratio of 5. This difference might be due to nanoparticle 
size. Nanoparticles with an N/P ratio of 5 are smaller than 
those with a ratio of 25, so antisense molecules have not 
enough space to diffuse through these smaller nanopar-
ticles and therefore remain on the surface. Also, there is a 
greater ionic interaction force between nanoparticles with 
an N/P ratio of 25 than nanoparticles with a ratio of 5, so 
release could be faster in nanoparticles with an N/P ratio of 
5 in PBS buffer. On the other hand, T 100%, which is the 
time necessary to reach the release percentage at steady-
state, is 50 ± 0.5 and 45 ± 0.7 hours in nanoparticles with 
N/P ratios of 5 and 25, respectively. There is a significant 
difference in release between these time points (P # 0.001), 
which means that nanoparticles with an N/P ratio of 5 can 
release antisense molecules at a slower rate than those with 
an N/P ratio of 25 as time passes, which could be due to 
faster erosion of the larger nanoparticles because of their 
greater surface area.
Drug stability
The stability of many colloidal systems is directly related 
to the magnitude of their zeta potential. In general, if the value 
of the particle zeta potential is large, the colloidal system 
will be stable. Conversely, if the particle zeta potential is 
relatively small, the colloidal system will become agglom-
erated. The surface charge of the particles is of substantial 
importance in all the production steps of these coated par-
ticles because the efficiency of the different steps is directly 
related to electrostatic interactions.13
Alg/Chi nanoparticles showed a positive zeta potential 
value of about +30 mV (see Table 1), which indicates good 
stability of the particle suspensions in aqueous medium. 
Nanoparticle size, zeta potential, and dissolution profiles 
were compared between freshly produced particles and 
those which had been resuspended following freeze-drying. 
SEM images showed that freeze-dried nanoparticles could 
swell again in aqueous medium and there was no signifi-
cant difference before and after the freeze-drying process. 
L    123456 7
Figure 3 gel electrophoresis analysis of alginate-chitosan nanoparticles. L (ladder), 
1 (naked As), 2 (N/P 5, one hour), 3 (N/P 5, three hours), 4 (N/P 5, three hours), 
5 (N/P 25, one hour), 6 (N/P 25, three hours), 7 (N/P 25, six hours). The image has 
been taken after staining by ethidium bromide and visualized under ultraviolet light.
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Figure 4 swellability of antisense-loaded alginate-chitosan nanoparticles with an N/P ratio of 5, in phosphate-buffered saline at ph 7.4.International Journal of Nanomedicine
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So   lyophilization can be used as a suitable method for the 
storage of these nanoparticles.15,16
Gel electrophoretic evaluation of nanoparticles incubated 
in aqueous medium showed that both nanoparticles with N/P 
ratios of 5 and 25 retained the antisense molecules, even after 
six hours of incubation, and remained intact in the wells. This 
indicates that the nanoparticles can retain and stabilize the 
content of antisense in their hydrogel matrix, although naked 
antisense migrated towards the bottom of the gel as a result 
of its low molecular weight (6300 Da) (Figure 3).3,17
Conclusions
Stability evaluation of freeze-dried Alg/Chi nanoparticles 
showed that this process does not change the characteristics 
of the nanoparticles and suggests that they could be a good 
storage method. Furthermore, nanoparticles can protect 
antisense molecules during the preparation and treatment 
periods. The release profile of EGFR antisense showed 
that these molecules can be released from nanoparticles over 
50 hours, and approximately 70% of the release occurred 
in the first five hours. These findings indicate that Alg/Chi 
nanoparticles may be good carriers for the delivery of anti-
sense oligonucleotides.
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